Douglas Flora, Executive Medical Director of Yung Family Cancer Center at St. Elizabeth Healthcare, President-Elect of the Association of Cancer Care Centers, and Editor in Chief of AI in Precision Oncology, shared a post by Fabien Curto Millet, Chief Economist at Google, adding:
“Permission to Prompt
People keep asking me the same question about AI in healthcare. Where do we start?
The real answer isn’t a vendor decision, a steering committee, or a twelve-month roadmap. It’s permission.
Dr. Fabien Curto Millet, Google’s Chief Economist, has been studying exactly this gap. In a recent UK study, only one in three employees used AI tools in their actual job. Then organizations added basic training, nothing elaborate, and usage doubled. The barrier wasn’t the technology. It wasn’t the cost. It was what Curto Millet calls permission to prompt — the explicit, stated confidence to experiment without fear of getting it wrong.
That gap shows up everywhere, but it’s strange to watch it in an industry that moves at the speed medicine does. The telegraph took roughly forty years to reach the world. So did the automobile. ChatGPT reached users in virtually every country within days. The technology arrived instantly. The permission did not.
Healthcare has the same problem. We just dress it up as compliance training and call it caution.
So if you’re asking where to start: stop waiting for the roadmap. Tell one person, specifically and out loud, that it’s safe to try.”
Quoting Fabien Curto Mille‘s post:
“Weiwen Qi and colleagues at the World Intellectual Property Organization – WIPO have posted a short article blending insights about AI diffusion from the latest World Intellectual Property Report with some observations I shared when I visited Geneva back in February. As the opening of the piece puts it:
AI is already here. It is already reshaping economies, industries, and jobs. The question is no longer whether it will change the world. The question is whether that change will work for everyone, or just a few.
More material at the link here.”
Other Articles Featuring Douglas Flora On OncoDaily.